Yizhe (Claudia) Chen
About Yizhe (Claudia) Chen
Yizhe (Claudia) Chen is a Senior Research Investigator at Bristol Myers Squibb in New Jersey, with a background in clinical pharmacology and data analysis.
Company
Yizhe (Claudia) Chen is currently employed at Bristol Myers Squibb, a global biopharmaceutical company headquartered in New York City, New York. She holds the position of Senior Research Investigator, a role she has been in since December 2020. Based in New Jersey, United States, Chen contributes to the company's ongoing research and development efforts.
Title
Yizhe (Claudia) Chen holds the title of Senior Research Investigator at Bristol Myers Squibb. In this capacity, she applies her expertise to designing clinical pharmacology studies, managing data analysis, interpreting results, reporting, and regulatory submission. Her role is crucial in ensuring the success of clinical trials and adherence to regulatory standards.
Education and Expertise
Yizhe (Claudia) Chen earned her Doctor of Philosophy (PhD) in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah, where she studied from 2009 to 2014. Prior to this, she completed her Bachelor of Science (BS) in Pharmacy at Shanghai Jiao Tong University, studying from 2005 to 2009. Chen has demonstrated expertise in clinical pharmacology study design, data analysis, and regulatory submissions.
Background
Before joining Bristol Myers Squibb, Yizhe (Claudia) Chen accumulated extensive research experience. She worked as a Scientist III at the University of Kentucky from 2016 to 2020 in Lexington, Kentucky Area. Prior to that, she was a Senior Research Technologist at St. Jude Children's Research Hospital in Memphis for one year, and a Graduate Research Assistant at the University of Utah College of Pharmacy for five years.
Achievements
Throughout her career, Yizhe (Claudia) Chen has contributed significantly to various research initiatives. Her roles have emphasized designing clinical studies, data management, and regulatory compliance, which are integral to advancing pharmaceutical research. Chen's extensive academic background and professional experience uniquely qualify her to lead research projects at a high level.